share_log

B of A Securities Initiates Coverage On Arrowhead Pharma With Buy Rating, Announces Price Target of $29

B of A Securities Initiates Coverage On Arrowhead Pharma With Buy Rating, Announces Price Target of $29

Bof A Securities以买入评级启动对Arrowhead Pharma的报道,宣布目标股价为29美元
Benzinga ·  2023/12/04 07:42

B of A Securities analyst Jason Gerberry initiates coverage on Arrowhead Pharma (NASDAQ:ARWR) with a Buy rating and announces Price Target of $29.

Bof A Securities分析师杰森·格伯里以买入评级开始对Arrowhead Pharma(纳斯达克股票代码:ARWR)进行报道,并宣布目标股价为29美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发